The conjugate demonstrated additive metabolic benefits of GLP-1 and estrogen to reverse obesity, hyperglycemia, and dyslipidemia in diet-induced obese (DIO) mice. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.